ACCS vs TECH · rev $23.1M vs P/E 65, rev $1.22B
ACCESS Newswire Inc. (ACCS) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
ACCESS Newswire Inc. (ACCS) is a advertising agencies company listed on AMEX.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported ACCS revenue for 2024-12-31 was $23.1M. Net income was -$10.8M. Revenue was down 6.0% from 2023-12-31 to 2024-12-31. ACCS currently screens at market cap $24.1M.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
ACCS currently screens at market cap $24.1M. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the ACCS and TECH stock pages for the full models.
Not investment advice.